How do I buy Neurocrine Biosciences (NBIX) stock?

You can purchase shares of Neurocrine Biosciences (NASDAQ:NBIX) through any online brokerage.View our list of the best stock brokerages

Who are Neurocrine Biosciences (NBIX) competitors?

Other companies in Neurocrine Biosciences’s space includes: Exact Sciences Corp (NASDAQ:EXAS), BeOne Medicines Ltd (NASDAQ:ONC), Ionis Pharmaceuticals Inc (NASDAQ:IONS), Roivant Sciences Ltd (NASDAQ:ROIV) and Amgen Inc (NASDAQ:AMGN).

What is the forecast, or price target, for Neurocrine Biosciences (NBIX) stock?

Neurocrine Biosciences has a consensus price target of $176.26.

What is the current price for Neurocrine Biosciences (NBIX)?

The stock price for Neurocrine Biosciences (NASDAQ: NBIX) is $132.39 last updated January 16, 2026 at 4:04 PM EST.

Does Neurocrine Biosciences (NBIX) pay a dividend?

There are no upcoming dividends for Neurocrine Biosciences.

When is Neurocrine Biosciences (NASDAQ:NBIX) reporting earnings?

Neurocrine Biosciences does not have any upcoming earnings scheduled.

Is Neurocrine Biosciences (NBIX) going to split?

There is no upcoming split for Neurocrine Biosciences.

What sector and industry does Neurocrine Biosciences (NBIX) operate in?

Neurocrine Biosciences is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

Neurocrine Biosciences (NBIX) Stock Price, Quote, News & History

Bulls vs Bears

Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Name

Revenue

Change

Gross

Change

EBITDA

Change

EBIT

Change

Earnings

Change

About

Sector

Health Care

Industry

Biotechnology

Neurocrine Biosciences Inc engages in the discovery, development, and commercialization of drugs for the treatment of neurological and endocrine-related diseases and disorders in the United States. The company's products include INGREZZA for tardive ...

Comments